Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9 Suppl 1
|
| pubmed:dateCreated |
1978-10-25
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0026-0495
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
27
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1295-8
|
| pubmed:dateRevised |
2011-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:210358-Animals,
pubmed-meshheading:210358-Cyclic GMP,
pubmed-meshheading:210358-Glucose,
pubmed-meshheading:210358-Insulin,
pubmed-meshheading:210358-Islets of Langerhans,
pubmed-meshheading:210358-Male,
pubmed-meshheading:210358-Oxidation-Reduction,
pubmed-meshheading:210358-Rats,
pubmed-meshheading:210358-Somatostatin
|
| pubmed:year |
1978
|
| pubmed:articleTitle |
Effects of somatostatin on insulin biosynthesis, glucose oxidation, and cyclic guanosine monophosphate level.
|
| pubmed:publicationType |
Journal Article,
In Vitro
|